I help bring new cancer and rare disease treatments to patients, guiding projects from early research all the way through clinical trials. Over the years, I’ve worked with a range of therapies – from small molecules and drug‐device combos to CAR-T/TCR-T cells, viral vector-based gene therapies, oncolytic viruses, antibodies, ADCs, and intratumoral delivery. I’ve led […]
I am Founder and Managing Director of Medsolve Dynamics, an oncology advisory firm focused on operational strategy, capital alignment, and reimbursement-driven purchasing for radiation oncology programs. I bring 20+ years of executive leadership across oncology technology, including senior roles at Varian, Mevion, ViewRay, and GE HealthCare, working at the intersection of oncology strategy and AI-enabled […]
I am the Clinical Chief of the Hematopathology Division, and a physician-scientist at Weill Cornell, where I combine my clinical and research skills to advance the understanding and diagnosis of hematological malignancies. I am actively involved in patient care through hematopathology diagnostics. For several years, I also directed the Multiparametric In Situ Imaging (MISI) Laboratory, […]
Physician-scientist and biotechnology professional with extensive expertise in clinical development, medical affairs, and real-world evidence across oncology, hematology, and cardiovascular medicine. Trained in medicine, epidemiology, biostatistics, and health economics, with experience bridging academic research and the life sciences industry. Adept at translating complex clinical and population-level data into actionable insights that drive therapeutic and medical […]
I am a Board Director at Novocure and a physician-scientist focused on oncology innovation, clinical development strategy, and translational medicine. As Professor of Clinical Medicine at Weill Cornell Medicine, I bring over two decades of leadership in precision oncology and clinical research. I help life sciences organizations translate scientific breakthroughs into clinically meaningful therapies by […]
With over 16 years of experience in cell biology, oncology drug discovery, and translational science, I support biotech and pharma teams in moving programs from early discovery toward preclinical readiness. My work focuses on building robust screening and validation strategies that improve decision quality before costly downstream development. I have led teams across major organizations […]